Inventor · disambiguated record
Marion Hitchcock
Also filed as: HITCHCOCK MARION
14 granted patents·20 pending applications·26 citations·filing 2008–2019
88Inventor score
Files withBayer Pharma AG17HITCHCOCK MARION5BAYER IP GMBH4BAYER HEALTHCARE AG1BAYER PHARMA AKITIENGESELLSCHAFT1
Top patents by PatentIndex Score
34 records- 0178US10266548B2Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2017·Granted Apr 23, 2019·2 cites·2 claims
- 0278US9643953B2Substituted benzylpyrazolesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·5 cites·10 claims
- 0377US9682974B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Jun 20, 2017·4 cites·8 claims
- 0475US9745285B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·3 cites·5 claims
- 0574US9765058B2Substituted benzylpyrazolesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·3 cites·14 claims
- 0674US9499547B2Amino-substituted imidazopyridazinesEIS KNUT·Filed 2012·Granted Nov 22, 2016·3 cites·16 claims
- 0773US8993630B2Substituted sulphonamido phenoxybenzamidesHARTUNG INGO·Filed 2009·Granted Mar 31, 2015·2 cites·11 claims
- 0866US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 0966US8673919B2Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitorsVERNIER JEAN-MICHEL·Filed 2010·Granted Mar 18, 2014·1 cites·22 claims
- 1064US10604532B2Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2019·Granted Mar 31, 2020·0 cites·6 claims
- 1162US9045429B2Substituted phenoxypyridinesHITCHCOCK MARION·Filed 2011·Granted Jun 2, 2015·1 cites·14 claims
- 1262US8962606B2Substituted benzosulphonamidesHITCHCOCK MARION·Filed 2010·Granted Feb 24, 2015·1 cites·13 claims
- 1361US2016046604A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1459US2016052912A1Diaminoheteroaryl substituted indazolesBAYER PHARMA AKITIENGESELLSCHAFT·Filed 2014·Application pending·0 cites
- 1554US2009082328A1Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activityBAYER HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 1653US2017275267A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1752US2014249133A1Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 1852US2011237592A1Substituted amido phenoxybenzamidesBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1951US2016046610A13-heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2051US2017283396A1Diaminoheteroaryl substituted indazolesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2149US2011071125A1Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activityRUDOLPH JOACHIM·Filed 2008·Application pending·0 cites
- 2248US2015141372A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2013·Application pending·0 cites
- 2347US2011039819A1Substituted phenoxybenzamidesHITCHCOCK MARION·Filed 2009·Application pending·0 cites
- 2445US2017275268A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2544US2016145267A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2644US2016168130A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2742US2016151370A1Substituted BenzylpyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2838US9381177B2Substituted N-(2-arylamino)aryl sulfonamide-containing combinationsPÜHLER FLORIAN·Filed 2011·Granted Jul 5, 2016·0 cites·10 claims
- 2935US2017275269A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3035US2017275270A1Benzyl substituted indazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3135US2017305882A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3233US10428044B23-amino-1,5,6,7-tetrahydro-4H-indol-4-onesBayer Pharma AG·Filed 2015·Granted Oct 1, 2019·0 cites·13 claims
- 3332US2012263714A1Substituted halophenoxybenzamide derivativesHITCHCOCK MARION·Filed 2010·Application pending·0 cites
- 3432US2012269803A1Substituted benzosulphonamidesHITCHCOCK MARION·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marion Hitchcock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →